LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

Kodu・Aktsiate loetelu・Vivani Medical

Vivani Medical

Suletud

1.14 0.88

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.12

Max

1.16

Põhinäitajad
By Trading Economics
Töötajad	37

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+247.83% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	12. nov 2025

Turustatistika
By TradingEconomics
Turukapital	-1.4M 62M
Eelmine avamishind	0.26
Eelmine sulgemishind	1.14

Vivani Medical Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

2. sept 2025, 23:07 UTC

Omandamised, ülevõtmised, äriostud

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2. sept 2025, 22:10 UTC

Suurimad hinnamuutused turgudel

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2. sept 2025, 21:47 UTC

Tulu

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2. sept 2025, 16:52 UTC

Suurimad hinnamuutused turgudel

CleanCore Solutions Shares Drop After $175 Million Private Investment

2. sept 2025, 22:47 UTC

Market Talk

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2. sept 2025, 21:40 UTC

Omandamised, ülevõtmised, äriostud

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2. sept 2025, 21:07 UTC

Tulu

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2. sept 2025, 21:07 UTC

Tulu

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2. sept 2025, 21:05 UTC

Tulu

Couche-Tard 1Q Rev $17.35B >ATD.T

2. sept 2025, 21:05 UTC

Tulu

Couche-Tard 1Q Adj EPS 78c >ATD.T

2. sept 2025, 21:05 UTC

Tulu

Couche-Tard 1Q EPS 82c >ATD.T

2. sept 2025, 21:05 UTC

Tulu

Couche-Tard 1Q Net $782.5M >ATD.T

2. sept 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

2. sept 2025, 20:53 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2. sept 2025, 20:51 UTC

Omandamised, ülevõtmised, äriostud

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2. sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2. sept 2025, 20:27 UTC

Tulu

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2. sept 2025, 20:24 UTC

Omandamised, ülevõtmised, äriostud

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2. sept 2025, 20:18 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2. sept 2025, 20:17 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2. sept 2025, 20:16 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2. sept 2025, 20:16 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2. sept 2025, 20:15 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2. sept 2025, 19:55 UTC

Tulu

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2. sept 2025, 19:50 UTC

Omandamised, ülevõtmised, äriostud

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2. sept 2025, 19:09 UTC

Market Talk

Oil Futures Gain on Geopolitical Premium -- Market Talk

2. sept 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2. sept 2025, 18:12 UTC

Market Talk

Gold Pushes To New Record -- Market Talk

2. sept 2025, 17:04 UTC

Market Talk

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2. sept 2025, 16:57 UTC

Omandamised, ülevõtmised, äriostud

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Vivani Medical Prognoos

Hinnasiht

By TipRanks

247.83% tõus

12 kuu keskmine prognoos

Keskmine 4 USD 247.83%

Kõrge 4 USD

Madal 4 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Vivani Medical 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

Osta

Hoia

Müü

Põhineb 2 analüütiku instrumendi Vivani Medical aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Ettevõttest Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.